Financials CVRx, Inc.

Equities

CVRX

US1266381052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
14.69 USD +2.08% Intraday chart for CVRx, Inc. -1.41% -53.28%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 248.9 377.7 654.4 317.2 - -
Enterprise Value (EV) 1 106.8 278.3 593.1 280.1 304.6 316
P/E ratio -2.94 x -9.08 x -15.8 x -7.51 x -9.45 x -17.2 x
Yield - - - - - -
Capitalization / Revenue 19.1 x 16.8 x 16.7 x 5.78 x 4.13 x 2.85 x
EV / Revenue 8.2 x 12.4 x 15.1 x 5.1 x 3.97 x 2.84 x
EV / EBITDA -4.14 x -6.61 x -16.3 x -7.34 x -10.1 x -15.1 x
EV / FCF -3.69 x -6.42 x -15 x -9.66 x -15.2 x -45.1 x
FCF Yield -27.1% -15.6% -6.68% -10.4% -6.57% -2.22%
Price to Book 1.71 x 3.47 x 8.64 x 5.65 x 8.74 x 10.1 x
Nbr of stocks (in thousands) 20,352 20,584 20,816 21,595 - -
Reference price 2 12.23 18.35 31.44 14.69 14.69 14.69
Announcement Date 2/15/22 1/26/23 1/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 13.04 22.47 39.3 54.89 76.74 111.4
EBITDA 1 - -25.8 -42.12 -36.28 -38.16 -30.13 -20.93
EBIT 1 - -25.97 -42.53 -43.1 -41.73 -33.35 -18.95
Operating Margin - -199.2% -189.27% -109.69% -76.03% -43.45% -17%
Earnings before Tax (EBT) 1 - -42.99 -41.32 -41.05 -42.41 -34.44 -20.48
Net income 1 -14.11 -43.08 -41.43 -41.2 -41.93 -34.4 -20.57
Net margin - -330.45% -184.38% -104.85% -76.38% -44.82% -18.47%
EPS 2 -37.18 -4.160 -2.020 -1.990 -1.957 -1.555 -0.8565
Free Cash Flow 1 - -28.92 -43.36 -39.61 -29 -20 -7
FCF margin - -221.81% -192.99% -100.81% -52.83% -26.06% -6.28%
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 4/9/21 2/15/22 1/26/23 1/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 3.395 3.658 4.076 5.031 6.186 7.176 7.979 9.5 10.51 11.3 11.37 13 14.56 15.95 16.41
EBITDA 1 -7.249 -8.732 -9.846 -10.92 -9.999 -11.35 -10.33 -10.15 -7.859 -7.942 -10.55 -10.04 -8.676 -9.052 -4.623
EBIT 1 -7.291 -8.788 -9.908 -11.01 -10.13 -11.48 -12.16 -11.75 -9.528 -9.661 -11.4 -10.87 -10.14 -9.699 -5.713
Operating Margin -214.76% -240.24% -243.08% -218.92% -163.69% -159.96% -152.43% -123.71% -90.65% -85.46% -100.25% -83.59% -69.59% -60.82% -34.81%
Earnings before Tax (EBT) 1 -6.11 -10.54 -9.965 -11.05 -9.798 -10.51 -11.34 -11.62 -8.971 -9.124 -11.36 -11.08 -10.09 -9.656 -5.841
Net income 1 -6.133 -10.57 -9.991 -11.07 -9.83 -10.54 -11.37 -11.65 -9.011 -9.163 -11.37 -11.09 -10.13 -9.665 -5.864
Net margin -180.65% -288.96% -245.12% -220.06% -158.91% -146.82% -142.51% -122.64% -85.73% -81.05% -99.96% -85.26% -69.53% -60.61% -35.73%
EPS 2 -0.3000 -0.5200 -0.4900 -0.5400 -0.4800 -0.5100 -0.5500 -0.5600 -0.4300 -0.4400 -0.5394 -0.5013 -0.4680 -0.4502 -0.3500
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/15/22 4/25/22 7/28/22 11/1/22 1/26/23 4/27/23 7/25/23 10/26/23 1/25/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 142 99.4 61.3 37.1 12.7 1.21
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -28.9 -43.4 -39.6 -29 -20 -7
ROE (net income / shareholders' equity) - -47.2% -32.5% -44.5% -63.9% -92.6% -99.5%
ROA (Net income/ Total Assets) - -39.6% -29.9% -34.3% -50.6% -63.5% -50.1%
Assets 1 - 108.7 138.7 120.1 82.94 54.14 41.1
Book Value Per Share 2 - 7.160 5.290 3.640 2.600 1.680 1.450
Cash Flow per Share - - - - - - -
Capex 1 - 1.18 0.69 0.59 1 1 1
Capex / Sales - 9.07% 3.05% 1.5% 1.82% 1.3% 0.9%
Announcement Date 4/9/21 2/15/22 1/26/23 1/25/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.69 USD
Average target price
34 USD
Spread / Average Target
+131.45%
Consensus